logo IDIBELL
Català  |   Castellano  |   English
Search
The InstituteResearchWhat's onPlatformsJoin usTools
 

Job offers


foto curriculum

Job offers

IDIBELL is a privileged place to work. A position made for you could be open soon.

Send CV


The Bellvitge Biomedical Research Institute is seeking a Clinical Trial Assistant (CTA) for the Legal Department.

Deadline: 30/11/2017
Description:

The IDIBELL is an entity that aims to promote, develop and disseminate biomedical research in the Bellvitge Campus, as well as encourage the transfer of technology and knowledge derived from research activities. 

More information


The Bellvitge Biomedical Research Institute is seeking for an Administrative profile for the Human Resources Department, with disability Certificate.

Deadline: 30/11/2017
Description:

The Bellvitge Biomedical Research Institute (IDIBELL) is a biomedical research center established in 2004. Its stakeholders are Bellvitge University Hospital and Viladecans Hospital of the Catalan Institute of Health, the Catalan Institute of Oncology, University of Barcelona and the town council of L’Hospitalet de Llobregat.

IDIBELL is located in L’Hospitalet de Llobregat, south of Barcelona. It is a member of the Campus of International Excellence of the University of Barcelona HUBc and part of the CERCA institution of the Generalitat of Catalonia. In 2009, it became one of the first five Spanish research centers accredited as a health research institute by the Carlos III Institute of Health.

More information


The Bellvitge Biomedical Research Institute is seeking for an Administrative profile for the Clinical Trials Unit, with disability Certificate.

Deadline: 30/11/2017
Description:

The Bellvitge Biomedical Research Institute (IDIBELL) is a biomedical research center established in 2004. Its stakeholders are Bellvitge University Hospital and Viladecans Hospital of the Catalan Institute of Health, the Catalan Institute of Oncology, University of Barcelona and the town council of L’Hospitalet de Llobregat.

IDIBELL is located in L’Hospitalet de Llobregat, south of Barcelona. It is a member of the Campus of International Excellence of the University of Barcelona HUBc and part of the CERCA institution of the Generalitat of Catalonia. In 2009, it became one of the first five Spanish research centers accredited as a health research institute by the Carlos III Institute of Health.

More information


IDIBELL is seeking Position for INPhINIT PhD student

Deadline: 31/12/2017
Description:

The Bellvitge Biomedical Research Institute (IDIBELL) is a biomedical research center stablished in 2004. Its stakeholders are Bellvitge University Hospital and Viladecans Hospital of the Catalan Institute of Health, the Catalan Institute of Oncology, University of Barcelona and the town council of L'Hospitalet de Llobregat

 

 

Research Group description:

How eukaryotes -including humans- inherit their nuclear genome is a fundamental question in biology which has direct clinical implications, as chromosome missegregation is a leading cause of miscarriages and birth defects, and is tightly linked to malignant tumour progression. Most aneuploid tumour cells are generated as a result of failed cytokinesis, which leads to cells containing both sets of sister chromatids. Hence, the regulation of mitosis is of paramount importance in maintaining chromosome stability. However, very little is known about mitotic exit regulation in any organism.

By studying the mechanisms that ensure completion of anaphase before cytokinesis, we hope to gain crucial insight into processes that are important for healthy growth and proliferation of all eukaryotes, including human.

 

Our current research is focused on the mechanisms that ensure faithful chromosome maintenance during healthy cell growth—particularly, the molecular framework responsible for the initiation of mitotic exit. We plan to extend established, state-of-the-art experimental systems using a model organism such as S. cerevisiae to study the regulation of mitosis and chromosome segregation. To address these questions we will use proteomic and genomic screens, as well as biochemical and functional studies.

 

For more information of the group you can visit http://www.idibell.cat/modul/cell-cycle/en

 


More information


More

 
© 2017 Institut d'Investigació Biomèdica de Bellvitge



Results by pageInitial date
Select date
TitleFinal date
Select date
Search


Your password is about to expire. Please, write in a new password to continue

Remember this password allows you to access to all IDIBELL’s web applications

New password:
Confirm new password:

Accept



Your password is about to expire. Please, write in a new password to continue

Remember this password allows you to access to all IDIBELL’s web applications

New password:
Confirm new password:

Accept


Cancell

Passwords doesn’t match
The password must have at least 6 characters
The new password can not contain special characters
User register

Name
Surname
Second Surname
E-mail
User
Password
Language


Accept


Cancell




Encara no heu contestat l'enquesta de satisfacció sobre la píndola formativa sobre patents. No trigareu més de cinc minuts a fer-ho. La vostra opinió és molt important per millorar l’IDIBELL.

Voleu fer l’enquesta ara?

Yes

No




Further personal and contact information is needed to maintain IDIBELL databases.

Do you wish to fill the form now?

Yes

No





Please, remember to introduce your holiday’s planning in the application

Accept

Cancell